Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Conditions

Hypogonadism 4Eunuchism 2Testicular Neoplasms 1Prostatic Neoplasms 1Prostate Cancer Recurrent 1Neoplasm Metastasis 1Multiple Endocrine Neoplasia Type 1 1Klinefelter Syndrome 1Infertility 1Fatigue Syndrome, Chronic 1Carcinoma, Renal Cell 1

Interventions

Testosterone 3testosterone undecanoate 2trametinib 1testosterone 17 beta-cypionate 1sotorasib 1selpercatinib 1pembrolizumab 1osimertinib 1lorlatinib 1dabrafenib 1cemiplimab 1brigatinib 1alectinib 1Pemetrexed 1Paclitaxel 1Nivolumab 1Gonadotropin-Releasing Hormone 1Gels 1Drug Evaluation 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Eunuchism × testosterone undecanoate × Clear all
NCT04049331 2026-04-22

Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone

Seattle Institute for Biomedical and Clinical Research

Phase 2 Active not recruiting
240 enrolled

Eunuchism, Hypogonadism, Fatigue Syndrome, Chronic

NCT02966652 2019-11-26

Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism

Neurocrine UK Limited

Phase 1 Completed
25 enrolled

Eunuchism, Hypogonadism, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡